MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma
MAP2K1 是厄洛替尼耐药头颈部鳞状细胞癌的潜在治疗靶点
期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-019-55208-5
Ankit P Jain, Krishna Patel, Sneha Pinto, Aneesha Radhakrishnan, Vishalakshi Nanjappa, Manish Kumar, Remya Raja, Arun H Patil, Anjali Kumari, Malini Manoharan, Coral Karunakaran, Saktivel Murugan, T S Keshava Prasad, Xiaofei Chang, Premendu Prakash Mathur, Prashant Kumar, Ravi Gupta, Rohit Gupta, Ar